JG
Insider
Jeremy Green
DirectorJeremy Green (Director) filed 3 Form 4 reports in the past 24 months (3 purchases, 2 sales, 1 filed past the two-business-day deadline), most often in ADCT. Across 3 priced purchase filings, the average 21-session return was -17.6% from execution and -11.5% from disclosure (delay-adjusted; derived). The largest single filing was $669K of FATE (397,964 sh × $1.68, as filed), executed Dec 20 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-17.6%
avg across 3 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-11.5%
same 3 filings, from disclosure
Filings, ttm
3
3 buys · 2 sells · 1 late
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.2M
shares × price, as filed
Last traded
Dec 20 2024
Filed Dec 26 2024
Median ADV $9.2M across their filed names
Open performance→Volume by month
Buys $1.4M
Sells $741K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
4 filings
Not on file
1 filing
Sector per market data · by filing · past 24 months
Most traded names
ADCT
ADCT
ADCT · 1 buy · 0 sells
1 filing
FATERecent filings
FATESALE
Fate Therapeutics, Inc.
View filing →
$574K341,633 sh × $1.68
Exec Dec 20 2024
Filed Dec 26 2024 · 5:30 PM ET † FATEPURCHASE Fate Therapeutics, Inc. View filing → $669K
397,964 sh × $1.68
Exec Dec 20 2024
Filed Dec 26 2024 · 5:30 PM ET † ADCTPURCHASE ADC Therapeutics SA View filing → $609K
200,000 sh across 4 lots
Exec Dec 11 2024
Filed Dec 13 2024 · 5:30 PM ET STTKSALE Shattuck Labs, Inc. View filing → $167K
133,371 sh × $1.25
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET STTKPURCHASE Shattuck Labs, Inc. View filing → $167K
133,371 sh × $1.25
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET